Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.
Pasqualini C, Furtwängler R, van Tinteren H, Teixeira RAP, Acha T, Howell L, Vujanic G, Godzinski J, Melchior P, Smets AM, Coulomb-L'Hermine A, Brisse H, Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Graf N, Verschuur AC. Pasqualini C, et al. Among authors: van den heuvel eibrink mm, van tinteren h. Eur J Cancer. 2020 Mar;128:38-46. doi: 10.1016/j.ejca.2020.01.001. Epub 2020 Mar 5. Eur J Cancer. 2020. PMID: 32109849 Free article. Clinical Trial.
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up.
Schrama JG, Faneyte IF, Schornagel JH, Baars JW, Peterse JL, van de Vijver MJ, Dalesio O, van Tinteren H, Rutgers EJ, Richelt DJ, Rodenhuis S. Schrama JG, et al. Among authors: van de vijver mj, van tinteren h. Ann Oncol. 2002 May;13(5):689-98. doi: 10.1093/annonc/mdf203. Ann Oncol. 2002. PMID: 12075736 Free article. Clinical Trial.
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.
Rodenhuis S, Bontenbal M, Beex LV, Wagstaff J, Richel DJ, Nooij MA, Voest EE, Hupperets P, van Tinteren H, Peterse HL, TenVergert EM, de Vries EG; Netherlands Working Party on Autologous Transplantation in Solid Tumors. Rodenhuis S, et al. Among authors: van tinteren h. N Engl J Med. 2003 Jul 3;349(1):7-16. doi: 10.1056/NEJMoa022794. N Engl J Med. 2003. PMID: 12840087 Free article. Clinical Trial.
Intracranial relapse in Wilms tumor patients.
van den Heuvel-Eibrink MM, Graf N, Pein F, Sandstedt B, van Tinteren H, van der Vaart KE, de Kraker J. van den Heuvel-Eibrink MM, et al. Among authors: van der vaart ke, van tinteren h. Pediatr Blood Cancer. 2004 Dec;43(7):737-41. doi: 10.1002/pbc.20150. Pediatr Blood Cancer. 2004. PMID: 15390287
Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer.
de Jong WK, Groen HJ, Koolen MG, Biesma B, Willems LN, Kwa HB, van Bochove A, van Tinteren H, Smit EF. de Jong WK, et al. Among authors: van bochove a, van tinteren h. Eur J Cancer. 2007 Nov;43(16):2345-50. doi: 10.1016/j.ejca.2007.07.029. Epub 2007 Sep 10. Eur J Cancer. 2007. PMID: 17826977 Clinical Trial.
Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups.
van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C, van Tinteren H, Rey A, Langford C, Anderson JR, de Kraker J. van den Heuvel-Eibrink MM, et al. Among authors: van tinteren h. Pediatr Blood Cancer. 2008 Jun;50(6):1130-4. doi: 10.1002/pbc.21389. Pediatr Blood Cancer. 2008. PMID: 18095319
323 results